Large variation in ESBL-producing Escherichia coli carriers in six European countries including Russia |
| |
| Authors: | Sofia Ny Roman Kozlov Uga Dumpis Petra Edquist Kirsi Gröndahl-Yli-Hannuksela Anna-Maria Kling Danuta O. Lis Christoph Lübbert Monika Pomorska-Wesołowska Ivan Palagin Aija Vilde Jaana Vuopio Jan Walter Karin Tegmark Wisell NoDARS ESBL-carrier working group |
| |
| Affiliation: | 1.Public Health Agency of Sweden,Stockholm,Sweden;2.Division of Clinical Microbiology, Department of Laboratory Medicine,Karolinska Institutet,Stockholm,Sweden;3.Institute of Antimicrobial Chemotherapy of Smolensk State Medical University,Smolensk,Russia;4.Pauls Stradins Clinical University Hospital,Rīga,Latvia;5.University of Turku,Turku,Finland;6.Institute of Occupational Medicine and Environmental Health,Sosnowiec,Poland;7.Division of Infectious Diseases and Tropical Medicine,Leipzig University Hospital,Leipzig,Germany;8.Robert Koch Institute,Berlin,Germany |
| |
| Abstract: | ![]()
We investigated the faecal carriage prevalence of extended-spectrum β-lactamase production in Escherichia coli (EP-EC) and/or Klebsiella pneumoniae (EP-KP) and risk factors associated with carriage among adult study subjects in Finland, Germany, Latvia, Poland, Russia and Sweden (partner countries). The aim was to get indicative data on the prevalence of ESBL-carriage in specific populations in the region. Faecal samples were collected from four study populations and screened on ChromID-ESBL and ChromID-OXA-48 plates. Positive isolates were further characterised phenotypically. Our results show a large variation in carrier prevalence ranging from 1.6% in Latvia to 23.2% in Russia for EP-EC. For the other partner countries, the prevalence of EP-EC were in increasing numbers, 2.3% for Germany, 4.7% for Finland, 6.6% for Sweden, 8.0% for Poland and 8.1% for all partner countries in total. Carriers of EP-KP were identified only in Finland, Russia and Sweden, and the prevalence was
|
| |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ |
|
